Aevice Health, a leading provider of remote monitoring solutions for chronic respiratory disease management, has raised $7 million Seed Plus Round led by Coronet Ventures, the Singapore-based venture unit of Cedars-Sinai Intellectual Property (CSIP) Co.

Participating in the round include East Ventures, A&D Company, Limited, NTUitive, Farquhar Venture Capital and existing investor Silicon Solution Venture, along with SEEDS Capital, the corporate investment arm of Enterprise Singapore.

The funding will be used to advance Singapore-based Aevice Health’s operations in key markets including US, Japan, and Singapore, leveraging the unique network each investor brings to each key market.

This investment builds on recent commercial and clinical milestones for Aevice Health, including successfully obtaining regulatory approvals for AeviceMD in the US and Singapore, entering a partnership with A&D Company, Limited in Japan, and establishing a clinical collaboration with Cedars-Sinai through the Cedars-Sinai Accelerator.

“Chronic respiratory disease continues to be a leading cause of death, yet solutions to address patient needs remain nascent and scarce. Aevice Health has developed one of the first remote patient monitors designed for chronic respiratory disease patients available in the market,” Adrian Ang, Chief Executive Officer of Aevice Health said. “We are grateful to have the support of our new and existing investors. Their investment reaffirms our commitment to bring impactful solutions to the lives of many suffering from chronic respiratory disease.”

Founded in 2018, Aevice Health has developed an award-winning remote monitoring platform featuring the world’s smallest smart wearable stethoscope to provide care for patients with chronic respiratory disease through the care continuum. Using a cutting-edge algorithm to analyse heart and lung sounds, the platform continuously monitors the patient for clinical deterioration by tracking biomarkers including respiratory rate, heart rate, and wheezing. By providing healthcare professionals with patients’ longitudinal data and the capability to utilise a remote stethoscope on their patients, Aevice Health’s solution enables comprehensive lung health assessments to be conveniently conducted from the patients’ homes.

Image caption- L-R- Derek Neo (Deputy General Manager, SEEDS Capital), Tan Kai Xin (General Manager, SEEDS Capital), Nirdesh K. Gupta, Ph.D. (Chief Executive Officer, Coronet Ventures), Adrian Ang (Chief Executive Officer, Aevice Health), Rex Tan (Chief Technology Officer, Aevice Health), Masatake Eto (Senior Advisor, A&D Company, Limited), Willson Cuaca (Co Founder and Managing Partner, East Ventures)